Erratum to: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B

By Chung Goh  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2509-2509

Springer Publishing Company

Access to resources Recommend Favorite

Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis B

By Wu Shuang   Fukai Kenichi   Imazeki Fumio   Arai Makoto   Kanda Tatsuo   Yonemitsu Yutaka   Yokosuka Osamu  

Digestive Diseases and Sciences, Vol. 56, Iss. 4, 2011-04 ,pp. : 1207-1214

Springer Publishing Company

Access to resources Recommend Favorite

Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine

By Hosaka Tetsuya   Suzuki Fumitaka   Suzuki Yoshiyuki   Saitoh Satoshi   Kobayashi Masahiro   Someya Takashi   Sezaki Hitomi   Akuta Norio   Arase Yasuji   Ikeda Kenji   Kumada Hiromitsu  

Journal of Gastroenterology, Vol. 42, Iss. 5, 2007-05 ,pp. : 368-374

Springer Publishing Company

Access to resources Recommend Favorite

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

By Sato Ken   Takagi Hitoshi   Kakizaki Satoru   Sohara Naondo   Mori Masatomo  

Journal of Gastroenterology, Vol. 41, Iss. 3, 2006-03 ,pp. : 283-285

Springer Publishing Company

Access to resources Recommend Favorite

Adefovir dipivoxil monotherapy is a sufficiently effective treatment modality for Japanese patients with lamivudine-resistant chronic hepatitis B

By Sato Ken   Takagi Hitoshi   Kakizaki Satoru   Sohara Naondo   Mori Masatomo  

Journal of Gastroenterology, Vol. 41, Iss. 9, 2006-09 ,pp. : 927-927

Springer Publishing Company

Access to resources Recommend Favorite